title: Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen.
abstract: The Tn antigen (GalNAc alpha-O-Ser/Thr) as defined by the binding of the lectin, helix pomatia agglutinin (HPA) or anti-Tn monoclonal antibodies, is known to be exposed in a majority of cancers, and it has also been shown to correlate positively with the metastatic capacity in breast carcinoma. The short O-glycan that forms the antigen is carried by a number of different proteins. One potential carrier of the Tn antigen is immunoglobulin A1 (IgA1), which we surprisingly found in tumour cells of the invasive parts of primary breast carcinoma. Conventional immunohistochemical analysis of paraffin-embedded sections from primary breast cancers showed IgA1 to be present in the cytoplasm and plasma membrane of 35 out of 36 individual primary tumours. The immunohistochemical staining of HPA and anti-Tn antibody (GOD3-2C4) did to some extent overlap with the presence of IgA1 in the tumours, but differences were seen in the percentage of stained cells and in the staining pattern in the different breast cancers analysed. Anti-Tn antibody and HPA were also shown to specifically bind to a number of possible constellations of the Tn antigen in the hinge region of IgA1. Both reagents could also detect the presence of Tn positive IgA in serum. On average 51% of the tumour cells in the individual breast cancer tumour sections showed staining for IgA1. The overall amount of staining in the invasive part of the tumour with the anti Tn antibody was 67%, and 93% with HPA. The intra-expression or uptake of IgA1 in breast cancer makes it a new potential carrier of the tumour associated and immunogenic Tn antigen.
authors: Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
authors: Charlotte
authors: C
authors: Welinder
authors: Bo
authors: B
authors: Baldetorp
authors: Ola
authors: O
authors: Blixt
authors: Dorthe
authors: D
authors: Grabau
authors: Bo
authors: B
authors: Jansson
mesh_terms: D000818:Animals; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D001943:Breast Neoplasms / Q000737:chemistry / Q000276:immunology* / Q000473:pathology; D045744:Cell Line, Tumor; D005260:Female; D006031:Glycosylation; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology* / Q000378:metabolism; D007150:Immunohistochemistry; D037102:Lectins / Q000276:immunology; D051379:Mice; D009361:Neoplasm Invasiveness / Q000276:immunology
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; C038095:Helix lectin; D007070:Immunoglobulin A; D037102:Lectins; C040286:Tn antigen
references: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12659-64
references: 11606714
references: Clin Chim Acta. 1996 Oct 15;254(1):47-61
references: 8894309
references: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17033-8
references: 15563589
references: J Proteome Res. 2012 Feb 3;11(2):692-702
references: 22067045
references: Cancer Res. 2006 Apr 15;66(8):3996-4000
references: 16618718
references: Histopathology. 1991 Nov;19(5):403-10
references: 1757079
references: Cell Mol Life Sci. 2013 Mar;70(5):829-39
references: 22864623
references: Biol Pharm Bull. 2008 Sep;31(9):1739-44
references: 18758069
references: Biochemistry. 2010 Jul 13;49(27):5671-82
references: 20507092
references: Oncol Rep. 2003 Sep-Oct;10(5):1577-85
references: 12883744
references: Glycobiology. 2006 Jan;16(1):54-64
references: 16135558
references: Cell Mol Immunol. 2012 Jan;9(1):54-61
references: 22036905
references: Lancet. 1987 May 9;1(8541):1054-6
references: 2883395
references: ACS Chem Biol. 2012 Jun 15;7(6):1031-9
references: 22444368
references: Cancer. 1975 Jul;36(1):221-4
references: 1203850
references: Glycobiology. 2011 Aug;21(8):1097-107
references: 21470982
references: Genes Chromosomes Cancer. 1998 May;22(1):83-6
references: 9591639
references: J Biol Chem. 1998 Jan 23;273(4):2260-72
references: 9442070
references: Vox Sang. 1985;48(2):116-21
references: 2416121
references: Cancer Immunol Immunother. 2009 Sep;58(9):1471-80
references: 19363676
references: World J Gastroenterol. 2007 Apr 28;13(16):2305-11
references: 17511028
references: Int J Cancer. 2001 Mar 20;95(2):79-85
references: 11241316
references: Mol Immunol. 2007 Mar;44(9):2221-7
references: 17174398
references: Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1770-91
references: 21259410
references: Cancer Res. 2011 Aug 1;71(15):5134-43
references: 21697279
references: Breast Cancer Res. 2010;12(3):204
references: 20550729
references: Cancer Res. 2003 Oct 1;63(19):6488-95
references: 14559841
references: J Exp Med. 2001 Aug 20;194(4):417-25
references: 11514599
references: Am J Pathol. 2009 Apr;174(4):1139-48
references: 19246641
references: Br J Cancer. 2001 Sep 28;85(7):1014-22
references: 11592774